Buprenorphine Sublingual C-III
Buprenorphine Sublingual C-III is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Buprenorphine Sublingual C-III. Available dosage form: tablet.
Drug Details
- Generic Name
- Buprenorphine Sublingual C-III
- Brand Names
- Buprenorphine Sublingual C-III
- Application Number
- ANDA078633
- Sponsor
- Direct_Rx
- NDC Codes
- 2
- Dosage Forms
- TABLET
- Routes
- SUBLINGUAL
- Active Ingredients
- BUPRENORPHINE HYDROCHLORIDE
Indications and Usage
Buprenorphine Sublingual Tablets are indicated for the treatment of opioid dependence and are preferred for induction. Buprenorphine Sublingual Tablets should be used as part of a complete treatment plan to include counseling and psychosocial support.